{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T09:42:40Z","timestamp":1786182160606,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02446-x","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T07:22:02Z","timestamp":1786173722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between metabolic dysfunction\u2013associated steatotic liver disease and physical and mental health\u2013related quality of life in older adults"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5049-9847","authenticated-orcid":false,"given":"Marzieh","family":"Nasr Azadani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Lotfaliany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeh","family":"Davoodian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Pasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Stocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart K.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gonzalez-Chica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice J.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aung Zaw Zaw","family":"Phyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Clayton-Chubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"issue":"4","key":"2446_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"1","key":"2446_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6(1):33.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"2446_CR3","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/hep.30125","volume":"68","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM. Patient\u2010reported outcomes and the economic effects of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: the value proposition. Hepatology. 2018;68(6):2405\u201312.","journal-title":"Hepatology"},{"issue":"25","key":"2446_CR4","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","volume":"381","author":"ZJ Ward","year":"2019","unstructured":"Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected US state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440\u201350.","journal-title":"N Engl J Med"},{"issue":"1","key":"2446_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"M Abdul Basith Khan","year":"2020","unstructured":"Abdul Basith Khan M, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes\u2014global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107\u201311.","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"2446_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","volume":"22","author":"V Manne","year":"2018","unstructured":"Manne V, Handa P, Kowdley KV. Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Clin Liver Dis. 2018;22(1):23\u201337.","journal-title":"Clin Liver Dis"},{"issue":"8","key":"2446_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036663","volume":"10","author":"X Ge","year":"1990","unstructured":"Ge X, Zheng L, Wang M, Du Y, Jiang J. Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990\u20132017: a population-based observational study. BMJ Open. 1990;10(8):e036663.","journal-title":"BMJ Open"},{"key":"2446_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41687-018-0052-7","volume":"2","author":"T Kennedy-Martin","year":"2018","unstructured":"Kennedy-Martin T, Bae JP, Paczkowski R, Freeman E. Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review. J Patient Report Outcomes. 2018;2:1\u201314.","journal-title":"J Patient Report Outcomes"},{"issue":"6","key":"2446_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2036.2007.03426.x","volume":"26","author":"A Dan","year":"2007","unstructured":"Dan A, Kallman J, Wheeler A, Younoszai Z, Collantes R, Bondini S, et al. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;26(6):815\u201320.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2446_CR10","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/hep.22868","volume":"49","author":"K David","year":"2009","unstructured":"David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB, et al. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49(6):1904\u201312.","journal-title":"Hepatology"},{"issue":"10","key":"2446_CR11","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.cgh.2018.12.016","volume":"17","author":"Y Huber","year":"2019","unstructured":"Huber Y, Boyle M, Hallsworth K, Tiniakos D, Straub BK, Labenz C, et al. Health-related quality of life in nonalcoholic fatty liver disease associates with hepatic inflammation. Clin Gastroenterol Hepatol. 2019;17(10):2085-92. e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2446_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-016-0420-z","volume":"14","author":"P Golabi","year":"2016","unstructured":"Golabi P, Otgonsuren M, Cable R, Felix S, Koenig A, Sayiner M, et al. Non-alcoholic fatty liver disease (NAFLD) is associated with impairment of health related quality of life (HRQOL). Health Qual Life Outcomes. 2016;14:1\u20137.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"2446_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/liv.15761","volume":"44","author":"CW Wernberg","year":"2024","unstructured":"Wernberg CW, Kjer MF, Gr\u00f8nkj\u00e6r LL, Jacobsen BG, Lauridsen MM. Steatotic liver disease is the most important somatic determinant of quality of life in patients with obesity: a cross\u2010sectional study. Liver Int. 2024;44(1):191\u2013201.","journal-title":"Liver Int"},{"issue":"9","key":"2446_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100525","volume":"4","author":"Z Younossi","year":"2022","unstructured":"Younossi Z, Aggarwal P, Shrestha I, Fernandes J, Johansen P, Augusto M, et al. The burden of non-alcoholic steatohepatitis: a systematic review of health-related quality of life and patient-reported outcomes. JHEP Rep. 2022;4(9):100525.","journal-title":"JHEP Rep"},{"key":"2446_CR15","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S437811","author":"W Yi","year":"2024","unstructured":"Yi W, Wu H, Fu W, Feng H, Huang J, Li H, et al. Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in non-obese patients with schizophrenia: a retrospective study. Diabetes Metab Syndr Obes. 2024. https:\/\/doi.org\/10.2147\/DMSO.S437811.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2446_CR16","doi-asserted-by":"publisher","first-page":"1042442","DOI":"10.3389\/fnins.2022.1042442","volume":"16","author":"A Gangopadhyay","year":"2022","unstructured":"Gangopadhyay A, Ibrahim R, Theberge K, May M, Houseknecht KL. Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines. Front Neurosci. 2022;16:1042442.","journal-title":"Front Neurosci"},{"issue":"10","key":"2446_CR17","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1111\/liv.16019","volume":"44","author":"H \u00c5str\u00f6m","year":"2024","unstructured":"\u00c5str\u00f6m H, Shang Y, Hagstr\u00f6m H, Wester A. Persons with metabolic dysfunction\u2010associated steatotic liver disease are at increased risk of severe depression. Liver Int. 2024;44(10):2551\u201363.","journal-title":"Liver Int"},{"issue":"1","key":"2446_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/acps.13239","volume":"143","author":"O Godin","year":"2021","unstructured":"Godin O, Leboyer M, Belzeaux R, Bellivier F, Loftus J, Courtet P, et al. Non\u2010alcoholic fatty liver disease in a sample of individuals with bipolar disorders: results from the FACE\u2010BD cohort. Acta Psychiatr Scand. 2021;143(1):82\u201391.","journal-title":"Acta Psychiatr Scand"},{"issue":"11","key":"2446_CR19","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/gerona\/glw342","volume":"72","author":"JJ McNeil","year":"2017","unstructured":"McNeil JJ, Woods RL, Nelson MR, Murray AM, Reid CM, Kirpach B, et al. Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study. The Journals of Gerontology: Series A. 2017;72(11):1586\u201393.","journal-title":"J Gerontol: Series A"},{"key":"2446_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107231","volume":"130","author":"ME Ernst","year":"2023","unstructured":"Ernst ME, Broder JC, Wolfe R, Woods RL, Nelson MR, Ryan J, et al. Health characteristics and aspirin use in participants at the baseline of the ASPirin in Reducing Events in the Elderly \u2013 eXTension (ASPREE-XT) observational study. Contemp Clin Trials. 2023;130:107231.","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"2446_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cct.2013.09.014","volume":"36","author":"Group AI","year":"2013","unstructured":"Group AI. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. Contemp Clin Trials. 2013;36(2):555\u201364.","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"2446_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294743","volume":"19","author":"EJ Parker","year":"2024","unstructured":"Parker EJ, Orchard SG, Gilbert TJ, Phung JJ, Owen AJ, Lockett T, et al. The ASPREE healthy ageing biobank: methodology and participant characteristics. PLoS ONE. 2024;19(2):e0294743.","journal-title":"PLoS ONE"},{"issue":"4","key":"2446_CR23","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/ije\/dyy279","volume":"48","author":"JJ McNeil","year":"2019","unstructured":"McNeil JJ, Woods RL, Ward SA, Britt CJ, Lockery JE, Beilin LJ, et al. Cohort profile: The ASPREE Longitudinal Study of Older Persons (ALSOP). Int J Epidemiol. 2019;48(4):1048\u20139.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2446_CR24","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s11357-024-01435-2","volume":"47","author":"D Clayton-Chubb","year":"2025","unstructured":"Clayton-Chubb D, Roberts SK, Majeed A, Woods RL, Tonkin AM, Nelson MR, et al. Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adults. Geroscience. 2025;47(1):1303\u201318.","journal-title":"Geroscience"},{"issue":"3","key":"2446_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware","year":"1996","unstructured":"Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"issue":"1","key":"2446_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1026409226544","volume":"8","author":"LLY Lim","year":"1999","unstructured":"Lim LLY, Fisher JD. Use of the 12-item Short-Form (SF-12) Health Survey in an Australian heart and stroke population. Qual Life Res. 1999;8(1):1\u20138.","journal-title":"Qual Life Res"},{"key":"2446_CR27","volume-title":"User\u2019s manual for the SF-12v2 Health Survey","author":"JE Ware","year":"2009","unstructured":"Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. User\u2019s manual for the SF-12v2 Health Survey. Lincoln, RI: QualityMetric; 2009."},{"issue":"1","key":"2446_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/liv.15725","volume":"44","author":"D Clayton-Chubb","year":"2024","unstructured":"Clayton-Chubb D, Kemp WW, Majeed A, Lubel JS, Woods RL, Tran C, et al. Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantage. Liver Int. 2024;44(1):39\u201351.","journal-title":"Liver Int"},{"issue":"9","key":"2446_CR29","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/nu17091415","volume":"17","author":"I Commins","year":"2025","unstructured":"Commins I, Clayton-Chubb D, Fitzpatrick JA, George ES, Schneider HG, Phyo AZZ, et al. Associations between MASLD, ultra-processed food and a Mediterranean dietary pattern in older adults. Nutrients. 2025;17(9):1415.","journal-title":"Nutrients"},{"issue":"1","key":"2446_CR30","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1097\/HEP.0000000000000966","volume":"81","author":"M El-Kassas","year":"2025","unstructured":"El-Kassas M, Alswat K. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2025;81(1):E8\u20139.","journal-title":"Hepatology"},{"issue":"3","key":"2446_CR31","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s11357-022-00547-x","volume":"44","author":"JT Neumann","year":"2022","unstructured":"Neumann JT, Thao LTP, Murray AM, Callander E, Carr PR, Nelson MR, et al. Prediction of disability-free survival in healthy older people. GeroScience. 2022;44(3):1641\u201355.","journal-title":"GeroScience"},{"issue":"7","key":"2446_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219200","volume":"14","author":"I Bosnes","year":"2019","unstructured":"Bosnes I, Nordahl HM, Stordal E, Bosnes O, Myklebust T\u00c5, Almkvist O. Lifestyle predictors of successful aging: a 20-year prospective HUNT study. PLoS ONE. 2019;14(7):e0219200.","journal-title":"PLoS ONE"},{"issue":"9","key":"2446_CR33","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1111\/jgs.14971","volume":"65","author":"K Franzon","year":"2017","unstructured":"Franzon K, Byberg L, Sj\u00f6gren P, Zethelius B, Cederholm T, Kilander L. Predictors of independent aging and survival: a 16\u2010year follow\u2010up report in octogenarian men. J Am Geriatr Soc. 2017;65(9):1953\u201360.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"2446_CR34","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/gerona\/glab340","volume":"77","author":"SE Espinoza","year":"2022","unstructured":"Espinoza SE, Woods RL, Ekram AS, Ernst ME, Polekhina G, Wolfe R, et al. The effect of low-dose aspirin on frailty phenotype and frailty index in community-dwelling older adults in the ASPirin in Reducing Events in the Elderly study. J Gerontol A Biol Sci Med Sci. 2022;77(10):2007\u201314.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9","key":"2446_CR35","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1007\/s00586-024-08369-5","volume":"33","author":"AM Klukowska","year":"2024","unstructured":"Klukowska AM, Vandertop WP, Schr\u00f6der ML, Staartjes VE. Calculation of the minimum clinically important difference (MCID) using different methodologies: case study and practical guide. Eur Spine J. 2024;33(9):3388\u2013400.","journal-title":"Eur Spine J"},{"issue":"4","key":"2446_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.knee.2019.04.018","volume":"26","author":"ND Clement","year":"2019","unstructured":"Clement ND, Weir D, Holland J, Gerrand C, Deehan DJ. Meaningful changes in the Short Form 12 physical and mental summary scores after total knee arthroplasty. Knee. 2019;26(4):861\u20138.","journal-title":"Knee"},{"key":"2446_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa209","author":"TP Lodise","year":"2020","unstructured":"Lodise TP, Colman S, Alexander E, Stein DS, Fitts D, Goldberg L, et al. Health-related quality of life as measured by the 12-item short-form survey among adults with community-acquired bacterial pneumonia who received either lefamulin or moxifloxacin in 2 phase III randomized, double-blind, double-dummy clinical trials. Open Forum Infect Dis. 2020. https:\/\/doi.org\/10.1093\/ofid\/ofaa209.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"2446_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0895-4356(03)00044-1","volume":"56","author":"RD Crosby","year":"2003","unstructured":"Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56(5):395\u2013407.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2446_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01344-w","volume":"18","author":"Y Mouelhi","year":"2020","unstructured":"Mouelhi Y, Jouve E, Castelli C, Gentile S. How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods. Health Qual Life Outcomes. 2020;18(1):136.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"2446_CR40","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582\u201392.","journal-title":"Med Care"},{"issue":"1","key":"2446_CR41","doi-asserted-by":"publisher","first-page":"21650","DOI":"10.1038\/s41598-024-72105-8","volume":"14","author":"M Michel","year":"2024","unstructured":"Michel M, Funuyet-Salas J, Doll M, Alqahtani SA, Armandi A, Labenz C, et al. Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosis. Sci Rep. 2024;14(1):21650.","journal-title":"Sci Rep"},{"issue":"6","key":"2446_CR42","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1016\/j.jhep.2024.02.010","volume":"80","author":"R Hashida","year":"2024","unstructured":"Hashida R, Nakano D, Kawaguchi M, Younossi ZM, Kawaguchi T. Changing from NAFLD to MASLD: the implications for health-related quality of life data. J Hepatol. 2024;80(6):e249\u201351.","journal-title":"J Hepatol"},{"key":"2446_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.585425","volume":"7","author":"J Funuyet-Salas","year":"2020","unstructured":"Funuyet-Salas J, P\u00e9rez-San-Gregorio M\u00c1, Mart\u00edn-Rodr\u00edguez A, Romero-G\u00f3mez M. Psychological biomarkers and fibrosis: an innovative approach to non-alcoholic fatty liver disease. Front Med. 2020;7:585425.","journal-title":"Front Med"},{"issue":"1","key":"2446_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2016-000106","volume":"3","author":"M Sayiner","year":"2016","unstructured":"Sayiner M, Stepanova M, Pham H, Noor B, Walters M, Younossi ZM. Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease. BMJ Open Gastroenterol. 2016;3(1):e000106.","journal-title":"BMJ Open Gastroenterol"},{"issue":"10","key":"2446_CR45","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.cgh.2019.01.001","volume":"17","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Stepanova M, Younossi I, Racila A. Validation of chronic liver disease questionnaire for nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2019;17(10):2093-100. e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2446_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glae011","author":"D Clayton-Chubb","year":"2024","unstructured":"Clayton-Chubb D, Kemp WW, Majeed A, Woods RL, Ryan J, Murray AM, et al. Late-life metabolic dysfunction-associated steatotic liver disease and its association with physical disability and dementia. J Gerontol A Biol Sci Med Sci. 2024. https:\/\/doi.org\/10.1093\/gerona\/glae011.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2446_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jpsychores.2018.07.004","volume":"112","author":"K Assimakopoulos","year":"2018","unstructured":"Assimakopoulos K, Karaivazoglou K, Tsermpini E-E, Diamantopoulou G, Triantos C. Quality of life in patients with nonalcoholic fatty liver disease: a systematic review. J Psychosom Res. 2018;112:73\u201380.","journal-title":"J Psychosom Res"},{"issue":"5","key":"2446_CR48","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.62347\/XLVA5738","volume":"17","author":"L Mou","year":"2025","unstructured":"Mou L, Yao H. Exploring the link between non-alcoholic fatty liver disease and depression: a systematic review and meta-analysis of bidirectional risk. American Journal of Translational Research. 2025;17(5):3691.","journal-title":"Am J Transl Res"},{"issue":"3","key":"2446_CR49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S2468-1253(24)00320-0","volume":"10","author":"ACD Mikkelsen","year":"2025","unstructured":"Mikkelsen ACD, Kj\u00e6rgaard K, Schapira AH, Mookerjee RP, Thomsen KL. The liver\u2013brain axis in metabolic dysfunction-associated steatotic liver disease. Lancet Gastroenterol Hepatol. 2025;10(3):248\u201358.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"2446_CR50","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1007\/s11136-021-02846-w","volume":"30","author":"A Vanier","year":"2021","unstructured":"Vanier A, Oort FJ, McClimans L, Ow N, Gulek BG, B\u00f6hnke JR, et al. Response shift in patient-reported outcomes: definition, theory, and a revised model. Qual Life Res. 2021;30(12):3309\u201322.","journal-title":"Qual Life Res"},{"issue":"4","key":"2446_CR51","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3350\/cmh.2022.0239","volume":"28","author":"MH Le","year":"2040","unstructured":"Le MH, Yeo YH, Zou B, Barnet S, Henry L, Cheung R, et al. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical Bayesian approach. Clin Mol Hepatol. 2040;28(4):841.","journal-title":"Clin Mol Hepatol"},{"issue":"Suppl 1","key":"2446_CR52","first-page":"S19","volume":"12","author":"A Nagral","year":"2022","unstructured":"Nagral A, Bangar M, Menezes S, Bhatia S, Butt N, Ghosh J, et al. Gender differences in nonalcoholic fatty liver disease. Euroasian J Hepato-Gastroenterol. 2022;12(Suppl 1):S19.","journal-title":"Euroasian J Hepato-Gastroenterol"},{"issue":"5","key":"2446_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4103\/sjg.sjg_122_24","volume":"30","author":"SA Alqahtani","year":"2024","unstructured":"Alqahtani SA, Alswat K, Mawardi M, Sanai FM, Abaakhail F, Alghamdi S, et al. Stigma in steatotic liver disease: a survey of patients from Saudi Arabia. Saudi Journal of Gastroenterology. 2024;30(5):335\u201341.","journal-title":"Saudi J Gastroenterol"},{"issue":"6","key":"2446_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11920-017-0784-8","volume":"19","author":"JS Tronieri","year":"2017","unstructured":"Tronieri JS, Wurst CM, Pearl RL, Allison KC. Sex differences in obesity and mental health. Curr Psychiatry Rep. 2017;19(6):29.","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"2446_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94189-2","volume":"11","author":"J Abildgaard","year":"2021","unstructured":"Abildgaard J, Ploug T, Al-Saoudi E, Wagner T, Thomsen C, Ewertsen C, et al. Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass. Sci Rep. 2021;11(1):14750.","journal-title":"Sci Rep"},{"issue":"6","key":"2446_CR56","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ijo.2008.25","volume":"32","author":"JC Lovejoy","year":"2008","unstructured":"Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. 2008;32(6):949\u201358.","journal-title":"Int J Obes"},{"issue":"5","key":"2446_CR57","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1210\/jc.2017-02449","volume":"103","author":"GE Papadakis","year":"2018","unstructured":"Papadakis GE, Hans D, Rodriguez EG, Vollenweider P, Waeber G, Marques-Vidal P, et al. Menopausal hormone therapy is associated with reduced total and visceral adiposity: the OsteoLaus cohort. J Clin Endocrinol Metab. 2018;103(5):1948\u201357.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2446_CR58","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1017\/S1041610212000634","volume":"24","author":"F Langlois","year":"2012","unstructured":"Langlois F, Vu TTM, Kergoat M-J, Chass\u00e9 K, Dupuis G, Bherer L. The multiple dimensions of frailty: physical capacity, cognition, and quality of life. Int Psychogeriatr. 2012;24(9):1429\u201336.","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"2446_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038079","volume":"7","author":"Y-W Chang","year":"2012","unstructured":"Chang Y-W, Chen W-L, Lin F-G, Fang W-H, Yen M-Y, Hsieh C-C, et al. Frailty and its impact on health-related quality of life: a cross-sectional study on elder community-dwelling preventive health service users. PLoS ONE. 2012;7(5):e38079.","journal-title":"PLoS ONE"},{"issue":"5","key":"2446_CR60","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/CCM.0000000000000860","volume":"43","author":"SM Bagshaw","year":"2015","unstructured":"Bagshaw SM, Stelfox HT, Johnson JA, McDermid RC, Rolfson DB, Tsuyuki RT, et al. Long-term association between frailty and health-related quality of life among survivors of critical illness: a prospective multicenter cohort study. Crit Care Med. 2015;43(5):973\u201382.","journal-title":"Crit Care Med"},{"key":"2446_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2019.103915","volume":"85","author":"P Vanleerberghe","year":"2019","unstructured":"Vanleerberghe P, De Witte N, Claes C, Verte D. The association between frailty and quality of life when aging in place. Arch Gerontol Geriatr. 2019;85:103915.","journal-title":"Arch Gerontol Geriatr"},{"issue":"20","key":"2446_CR62","doi-asserted-by":"publisher","first-page":"eaeg4939","DOI":"10.1126\/sciadv.aeg4939","volume":"12","author":"R Jiang","year":"2026","unstructured":"Jiang R, Rosenblatt M, Qi S, Calhoun VD, Wang Q, Wang P, et al. The metabolomic signatures mediate associations between physical frailty and metabolic dysfunction\u2013associated steatotic liver disease. Sci Adv. 2026;12(20):eaeg4939.","journal-title":"Sci Adv"},{"issue":"4","key":"2446_CR63","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3390\/jcm15041661","volume":"15","author":"H Nishikawa","year":"2026","unstructured":"Nishikawa H, Kim SK, Yoshio S, Asai A. Metabolic dysfunction-associated steatotic liver disease and sarcopenia: review of literature. J Clin Med. 2026;15(4):1661.","journal-title":"J Clin Med"},{"issue":"9","key":"2446_CR64","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2446_CR65","unstructured":"MAFLD Consensus Statement Working Group. Recommendations for the assessment of metabolic dysfunction-associated fatty liver disease (MAFLD) in primary care: a consensus statement Melbourne: Gastroenterological Society of Australia. 2024. https:\/\/www.gesa.org.au\/public\/13\/files\/Education%20%26%20Resources\/Clinical%20Practice%20Resources\/MAFLD\/MAFLD%20consensus%20statement%202024.pdf. Accessed 15 Mar 2025."},{"issue":"1","key":"2446_CR66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/oby.2004.10","volume":"12","author":"LL Yan","year":"2004","unstructured":"Yan LL, Daviglus ML, Liu K, Pirzada A, Garside DB, Schiffer L, et al. BMI and health-related quality of life in adults 65 years and older. Obes Res. 2004;12(1):69\u201376.","journal-title":"Obes Res"},{"issue":"8","key":"2446_CR67","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/ggi.70103","volume":"25","author":"HJ Lee","year":"2025","unstructured":"Lee HJ, Hong JM, Lim C, Kim J-H. Walking exercise has a stronger association with quality of life in obese older adults than in non-obese older adults: a nationwide population-based study. Geriatr Gerontol Int. 2025;25(8):1065\u201373.","journal-title":"Geriatr Gerontol Int"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02446-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T09:02:16Z","timestamp":1786179736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02446-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":67,"alternative-id":["2446"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02446-x","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}